Begin main content

Reports

We found 6501 result(s)

inotersen (Tegsedi)

Last Updated: August 9, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: inotersen
Indications: hereditary transthyretin amyloidosis

  • Brand Name: Tegsedi
  • Manufacturer: Akcea Therapeutics Inc.
  • Project Number: SR0603-000
  • Project Status: Active
  • Submission Type: New

baricitinib (Olumiant )

Last Updated: August 8, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: baricitinib
Indications: Arthritis, Rheumatoid

  • Brand Name: Olumiant
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0597-000
  • Project Status: Active
  • Submission Type: New

burosumab (Crysvita)

Last Updated: August 8, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: burosumab
Indications: Treatment of X-Linked Hypophosphatemia

  • Brand Name: Crysvita
  • Manufacturer: Kyowa Kirin Limited
  • Project Number: SR0602-000
  • Project Status: Active
  • Submission Type: New

Ivabradine (Lancora) for Heart Failure

Last Updated: August 8, 2019
Result type: Reports
Product Line: Technology Review

Heart failure is a condition characterized by reduced cardiac output occurring due to complications of cardiovascular disease. It is a leading cause of hospital admissions and has a poor prognosis. The 2017 Canadian Cardiovascular Society guidelines recommend that ivabradine be considered in patients with a reduced left ventricular ejection frac...

  • Project Number: HO0006-000

upadacitinib (TBC)

Last Updated: August 2, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: upadacitinib
Indications: Arthritis, Rheumatoid

  • Brand Name: TBC
  • Manufacturer: AbbVie
  • Project Number: SR0614-000
  • Project Status: Active
  • Submission Type: New